Institutul National de Endocrinologie C.I. Parhon
- Address
- Bulevardul Aviatorilor 34-36, Bucharest, Romania
Institutul National de Endocrinologie C.I. Parhon - Cortisol Disorders Research Center
The Institutul National de Endocrinologie C.I. Parhon stands as a leading center for endocrinology research in Romania, with specialized expertise in rare hormonal disorders. The institute focuses on advancing treatment options for patients suffering from conditions related to excessive cortisol production, conducting innovative clinical trials that evaluate novel therapeutic approaches for these challenging endocrine disorders.
- Cushing's Disease and hypercortisolism management
- Adrenal tumor-related hormonal complications
- Novel pharmacological interventions for cortisol regulation
The center's research portfolio emphasizes the evaluation of emerging treatments for hypercortisolism related to various etiologies, including Cushing's Disease and autonomous cortisol secretion (ACS) from benign adrenal tumors. Their clinical trial program investigates both the efficacy and safety profiles of investigational medications, along with detailed pharmacokinetic assessments to optimize therapeutic strategies for patients with these rare and serious hormonal disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1H. Lundbeck A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institutul National de Endocrinologie C.I. Parhon
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of SPI-62 for the Management of Hypercortisolism Associated with Benign Adrenal Tumors | Sparrow Pharmaceuticals Inc. | Phase II | Not Recruiting | — | Feb 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 4-{5-[2-(4-Chloro-2,6-Difluorophenoxy)Propan-2-Yl]-4-Methyl-4H-1,2,4-Triazol-3-Yl}-3-Fluorobenzamide | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.